Halozyme Therapeutics
HALO
#2117
Rank
S$9.87 B
Marketcap
$80.18
Share price
1.04%
Change (1 day)
43.70%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): S$0.74 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.01 Billion. , an increase over its 2023 earnings that were of S$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 S$0.74 B59.94%
2023 S$0.46 B39.94%
2022 S$0.33 B0.16%
2021 S$0.33 B92.2%
2020 S$0.17 B-278.96%
2019 -S$96.32 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$82.12 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$42.97 Million-52.86%
2014 -S$91.15 Million-18.09%
2013 -S$0.12 Billion55.88%
2012 -S$71.39 Million169.94%
2011 -S$26.45 Million-63.44%
2010 -S$72.33 Million-7.19%
2009 -S$77.93 Million15.91%
2008 -S$67.24 Million83.89%
2007 -S$36.57 Million78.1%
2006 -S$20.53 Million16%
2005 -S$17.7 Million45.24%
2004 -S$12.19 Million682.42%
2003 -S$1.56 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$33.37 M-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.90 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.22 B-70.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.25 B 1,146.20%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.58 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
S$23.25 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA